<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.ijbiomac.2023.123373</dc:identifier><dc:language>eng</dc:language><dc:creator>Ortega Alarcon, David</dc:creator><dc:creator>Claveria Gimeno, Rafael</dc:creator><dc:creator>Vega, Sonia</dc:creator><dc:creator>Jorge Torres, Olga C.</dc:creator><dc:creator>Esteller, Manel</dc:creator><dc:creator>Abian, Olga</dc:creator><dc:creator>Velazquez Campoy, Adrian</dc:creator><dc:title>Unexpected thermodynamic signature for the interaction of hydroxymethylated DNA with MeCP2</dc:title><dc:identifier>ART-2023-133170</dc:identifier><dc:description>Hydroxymethylated cytosine (5hmC) is a stable DNA epigenetic mark recognized by methyl-CpG binding protein 2 (MeCP2), which acts as a transcriptional regulator and a global chromatin-remodeling element. Because 5hmC triggers a gene regulation response markedly different from that produced by methylated cytosine (5mC), both modifications must affect DNA structure and/or DNA interaction with MeCP2 differently. MeCP2 is a six-domain intrinsically disordered protein (IDP) with two domains responsible for dsDNA binding: methyl-CpG binding domain (MBD) and intervening domain (ID). Here we report the detailed thermodynamic characterization of the interaction of hmCpG-DNA with MeCP2. We find that hmCpG-DNA interacts with MeCP2 in a distinctly different mode with a particular thermodynamic signature, compared to methylated or unmethylated DNA. In addition, we find evidence for Rett syndrome-associated mutations altering the interaction of MeCP2 with dsDNA in a cytosine modification-specific manner which may correlate with disease onset time and clinical severity score.</dc:description><dc:date>2023</dc:date><dc:source>http://zaguan.unizar.es/record/153217</dc:source><dc:doi>10.1016/j.ijbiomac.2023.123373</dc:doi><dc:identifier>http://zaguan.unizar.es/record/153217</dc:identifier><dc:identifier>oai:zaguan.unizar.es:153217</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B25-20R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/DGA/E45-20R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/ISCIII/CIBERehd</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/ISCIII/CPII13-00017</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/ISCIII-ERDF-ESF/PI18-00349-Investing in your future</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MICINN/AEI/PID2021-127296OB-I00</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/FEDER/BFU2016-78232-P</dc:relation><dc:identifier.citation>International journal of biological macromolecules 232 (2023), 123373 [13 pp]</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>